DSG2 and prostate carcinoma: To assess the percentage of cells positive for DSG2 expression in prostate carcinoma as compared to normal prostate tissue, immunofluorescence analysis of DSG2 expression was performed on prostate carcinoma TMAs (n = 414) as well as normal prostate TMAs (n = 50).